Ultrasonic Electrosurgical Market Size, Share, and Industry Analysis By Product (Generators and Consumables [Shears, Electrodes, Pencils, and Others (Scalpels, Forceps)]), By Type (High-intensity Focused Ultrasonic (HIFU) Ablation Systems, Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablation Systems, and Ultrasonic Surgical Ablation Systems), By Application (Gynecology, General Surgery, Neurology, Urology, Bariatric Surgery, and Others (Thoracic Surgery, ENT Surgery)), By End User (Hospitals and ASCs, Specialty Clinics, and Others), and Regional Forecast till 2032

The global ultrasonic electrosurgical market is witnessing significant growth due to a high product demand in minimally invasive procedures. These surgeries are gaining popularity owing to various benefits such as smaller incisions, less pain, and reduced time of recovery. Compared to traditional procedures, ultrasonic electrosurgery is preferred on account of advantages such as improved hemostasis, reduced thermal damage, and precise tissue cutting.  

• According to NCBI (National Center for Biotechnology Information), ultrasonic dissection depicts a 17 minutes reduction in operating time in acute cholecystitis cases. Furthermore, during tissue dissection, ultrasonic devices generate a temperature range of 60°C to 100°C.

Ultrasonic Electrosurgical Market Driver

Surging Prevalence of Chronic Disorders

The escalating prevalence of chronic diseases pushes the adoption of ultrasonic electro surgeries. Obesity, cardiovascular diseases, and cancer are some of the major chronic disorders recorded across the globe. The increasing geriatric population is bolstering the incidence of age-related conditions that require surgical interventions. The benefit of reduced complexities enabled by the adoption of ultrasonic electrosurgical devices in these procedures drives their demand across various applications in the medical sector.

• According to the U.S. FDA (Food and Drug Administration), ultrasonic surgical procedures exhibit 0.7% to 6.5% incidence rate of complications, as depicted across nine studies.

Ultrasonic Electrosurgical Market Restraint

High Device Cost and Lack of Skilled Operators May Create Challenges

The expenses associated with ultrasonic electrosurgical devices may hinder their deployment. Furthermore, skilled personnel are required for operating these devices. The lack of trained operators is a key factor that may create challenges for the expansion of the market in developing countries.

Moreover, the stringent regulatory landscape in some countries may create hindrances in the launch of new and advanced devices, affecting product penetration in these areas.

Ultrasonic Electrosurgical Market Opportunity

Escalating Cosmetic Surgeries Demand and Development of Cost-effective Devices

The escalating demand for cosmetic surgeries is anticipated to drive the device demand, opening doors to new opportunities for market players. Furthermore, manufacturers are keen to develop cost-effective and compact devices. Such equipment is being introduced for enhancing accessibility to patients and healthcare providers.

Another significant opportunity for industry players is the integration of robotic surgery systems with ultrasonic electrosurgical procedures. Such technological breakthroughs are anticipated to support the quality of healthcare services and bolster industry expansion over the forthcoming years.

Segmentation

Key Insights

The report covers the following key insights:

• Key Ultrasonic Electrosurgical Procedures and Demand Statistics
• Major Factors Influencing the Demand for Ultrasonic Electrosurgical Devices
• Business Strategies Adopted by Key Players
• Government and Regulatory Framework across Key Countries
• Key Industry Developments (Mergers, Acquisitions, Partnerships)

Analysis by Product

Based on product, the ultrasonic electrosurgical market is divided into generators and consumables [shears, electrodes, pencils, and others (scalpels, forceps)].

The generators segment is estimated to hold a leading market share with an increase in the utilization of these products in surgeries. The product usage helps offer numerous advantages such as shorter times of operation and reduced blood loss. Furthermore, the precision offered by these devices help in improving patient outcomes.

The consumables segment is witnessing significant growth driven by a rise in the demand for pencils and electrodes in various surgical procedures. The enhanced hemostasis, lower thermal damage, and precision in cutting offered by these products boosts their adoption. For instance, according to SAGES (Society of American Gastrointestinal and Endoscopic Surgeons), the mean maximal temperature touched by the Voyant™ device tip is 103.08°C.

Analysis by Type

On the basis of type, the ultrasonic electrosurgical market is subdivided into high-intensity focused ultrasonic (HIFU) ablation systems, magnetic resonance-guided focused ultrasonic (MRGFUS) ablation systems, and ultrasonic surgical ablation systems.

The demand for ultrasonic surgical ablation systems is expanding, driven by a surge in the popularity of minimally invasive procedures, which record an escalated adoption of these systems. The segment is expected to dominate the global market with an increase in healthcare expenditure across various countries and a rise in reimbursement programs that cover these surgeries.  

HIFU (high-intensity focused ultrasonic) ablation systems are witnessing a high demand with their adoption in HIFU procedures. These surgeries are used for the treatment of conditions such as tremors, uterine fibroids, and tumors. Owing to these factors, the segment is estimated to grow at a significant pace over the coming years.

Analysis by Application

By application, the market is fragmented into gynecology, general surgery, neurology, urology, bariatric surgery, and others (thoracic surgery, ENT surgery)).

The gynecology sector depicts a rise in product adoption in various procedures given the enhanced patient outcomes and the advantage of reduced complications. Some of the procedures exhibiting a high deployment of ultrasonic electrosurgical devices comprise ovarian cystectomy, myomectomy, and hysterectomy, among others. The segment is projected to grow at a considerable rate over the forthcoming years.

The neurology segment is depicting significant expansion due to the increasing adoption of ultrasonic technology for neurosurgical procedures. The rising prevalence of various neurological conditions such as spinal disorders and brain tumors is propelling the demand for minimally invasive procedures and boosting product deployment.

Analysis by End User

Based on end user, the ultrasonic electrosurgical market is subdivided into hospitals and ASCs, specialty clinics, and others.

The hospitals and ASCs segment is projected to dominate the global market owing an increase in patient visits and admissions for various surgical procedures. The availability of advanced healthcare infrastructure and skilled professionals increases the patient preference for these establishments and drives product adoption. According to NCBI, ultrasonic dissection reduces the mean length of hospital stays by 0.3 days.

The specialty clinics segment is slated to witness significant growth with increasing visits to these centers for consultations and health checkups amid increasing health consciousness across the globe. An increase in various cardiovascular and chronic diseases is a key factor influencing health concerns across various regions.

Regional Analysis

On the basis of geography, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America depicts a rising demand for minimally invasive surgeries and the presence of advanced healthcare infrastructure. The region also exhibits high spending on healthcare, which is a major factor influencing its dominance in the global market. The product adoption is also rising with the presence of a well-established reimbursement framework in the U.S.

In Europe, the mounting demand for advanced surgical tools and escalating access to cutting edge surgical technology drives the adoption of ultrasonic electrosurgical devices. The growing aging population in Europe and the presence of a favorable regulatory landscape are additional factors pushing market expansion.  

The Asia Pacific ultrasonic electrosurgical industry is anticipated to record significant expansion over the ensuing years favored by the escalating chronic diseases’ burden in countries such as India and China. The region exhibits a surge in medical tourism and increasing advancements in healthcare infrastructure.

Key Players Covered

The report includes the profiles of the following key players:

• Johnson & Johnson Services, Inc. (Ethicon US, LLC) (U.S.)
• Olympus Corporation (Japan)
• Medtronic (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Surgnova (China)
• Bioventus (U.S.)
• Miconvey (China)
• Reach Surgical (China)
• BOWA MEDICAL (Germany)
• Wuhan BBT Mini-invasive Medical Tech. Co., Ltd. (China)
• Integra LifeSciences Corporation (U.S.)
• Insightec (Israel)
• EDAP TMS (France)

Key Industry Developments

• In September 2022, Olympus Corporation announced the commercial launch of THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery in Japan. The device forms part of the company’s hybrid energy devices’ portfolio. The device would be launched in the U.S., Europe, and South Korea in October 2022.  
• In June 2021, Ethicon announced the rollout of the ENSEAL X1 Curved Jaw Tissue Sealer. The solution is an advanced bipolar energy device that offers stronger sealing and enhances procedural efficiency.
• In September 2020, Medtronic rolled out Sonicision, a curved jaw cordless ultrasonic dissection system. The solution has been equipped to provide the integrated benefits of improved precision to surgeons. The device can be utilized as a substitute or adjunct for lasers, electrosurgery, and steel scalpels in plastic, general, gynaecologic, urologic, pediatric, and endoscopic procedures.
• In July 2020, Lexington Medical struck a partnership with BOWA Medical under which the companies would sell the LOTUS and AEON portfolios in numerous markets across the globe.